Processa Pharmaceuticals, Inc.
PCSA
$1.99
-$0.17-7.87%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -97.17% | -41.63% | 364.79% | 118.17% | 24.51% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 642.83% | -71.26% | -80.53% | -86.68% | -90.13% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -71.11% | -48.42% | 201.77% | 36.14% | -4.34% |
|
|
|||||
| Total Current Assets | -71.11% | -48.42% | 201.77% | 36.14% | -4.34% |
| Net Property, Plant & Equipment | -88.85% | -93.33% | -94.98% | -95.84% | -75.57% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 158.12% | 67.84% | 17,967.27% | 18,067.27% |
| Total Assets | -74.70% | -6.00% | 141.96% | 53.47% | 7.64% |
|
|
|||||
| Total Accounts Payable | 111.17% | 52.08% | 19.97% | 2.18% | -17.55% |
| Total Accrued Expenses | -42.41% | 67.43% | 103.82% | 148.01% | 149.94% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -72.53% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 15.05% | 54.33% | 45.92% | 43.62% | 33.70% |
|
|
|||||
| Total Current Liabilities | 15.05% | 54.33% | 45.92% | 43.62% | 33.70% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 15.05% | 54.33% | 45.87% | 43.36% | 31.53% |
|
|
|||||
| Common Stock & APIC | 6.69% | 13.66% | 19.55% | 17.00% | 14.83% |
| Retained Earnings | -14.30% | -15.66% | -15.55% | -15.31% | -15.88% |
| Treasury Stock & Other | -- | -- | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -105.20% | -27.95% | 228.81% | 56.78% | 1.39% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -105.20% | -27.95% | 228.81% | 56.78% | 1.39% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -105.20% | -27.95% | 228.81% | 56.78% | 1.39% |
|
|
|||||